ThaiPR.NET https://www.thaipr.net/location/geneva-switzerland Press Release Distribution Center of Thailand Mon, 27 Apr 2026 18:55:56 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[MedAlliance Acquired by Cordis for up to USD 1.135 Billion]]> https://www.thaipr.net/en/health_en/3391115 Tue, 03 Oct 2023 11:35:24 +0700 health_en https://www.thaipr.net/en/health_en/3391115 Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing payment of $200M, together with regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029, for a total consideration of up to $1.135 Billion. Cordis is a worldwide […]

The post MedAlliance Acquired by Cordis for up to USD 1.135 Billion appeared first on ThaiPR.NET.

]]> <![CDATA[First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR]]> https://www.thaipr.net/en/health_en/3239933 Fri, 16 Sep 2022 08:00:00 +0700 health_en https://www.thaipr.net/en/health_en/3239933 An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon.   The PERFECT-SELUTION FIM (PElvic Revascularization For EreCTile dysfuction-SELUTION First-In-Man) study involves a total of 54 patients suffering from distal internal pudendal-penile artery stenotic disease and ED. They are […]

The post First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR appeared first on ThaiPR.NET.

]]> <![CDATA[First US Patient Enrolled in SELUTION SLR IDE Peripheral Study]]> https://www.thaipr.net/en/health_en/3229498 Wed, 24 Aug 2022 12:45:09 +0700 health_en https://www.thaipr.net/en/health_en/3229498 The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approval in the US in May 2022, with enrollment of the first patient occurring in Germany one week after approval.   “We are very excited to finally […]

The post First US Patient Enrolled in SELUTION SLR IDE Peripheral Study appeared first on ThaiPR.NET.

]]> <![CDATA[Huawei Intelligent Net-Zero Carbon Campus Solution Wins WSIS Prize 2022 Champion]]> https://www.thaipr.net/en/energy_en/3197639 Thu, 02 Jun 2022 16:00:01 +0700 energy_en https://www.thaipr.net/en/energy_en/3197639 Huawei was named Champion at the World Summit on the Information Society (WSIS) 2022 Forum’s Prizes Ceremony in Geneva yesterday. The WSIS 2022 Prizes Champion, was presented to Huawei for its use of their intelligent net-zero carbon campus solution at the Yancheng Low-carbon & Smart Energy Industrial Park project. A total of 996 projects were […]

The post Huawei Intelligent Net-Zero Carbon Campus Solution Wins WSIS Prize 2022 Champion appeared first on ThaiPR.NET.

]]>